1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Attenuated familial adenomatous polyposis: new trials by email Literature Review of Attenuated familial adenomatous polyposis trials Research Report on Attenuated familial adenomatous polyposis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing Obeticholic Acid for Familial Adenomatous Polyposis Biopsy Procedure, Biospecimen Collection, Gastrointestinal Endoscopy - Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 15 | 2023-01-19 | 2026-05-14 |
| Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer Erlotinib, Erlotinib Hydrochloride - Attenuated Familial Adenomatous Polyposis, Familial Adenomatous Polyposis | Phase 2 | Completed | National Cancer Institute (NCI) | 46 | 2017-10-27 | 2022-07-26 |
Adenomatous Polyposis Coli (2) · Colorectal Neoplasms (1) · Duodenal Neoplasms (1)
Adenoma (2) · Adenomatous Polyps (2) · Colonic Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Genetic Diseases, Inborn (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Intestinal Polyposis (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2)
Biopsy (1) · Endoscopy, Gastrointestinal (1) · Erlotinib Hydrochloride (1) · Specimen Handling (1) · obeticholic acid (1)
National Cancer Institute (NCI) (2)
Puerto Rico (2) · United States (2)
Eduardo Vilar-Sanchez (1) · Niloy J Samadder (1)
N01CN00042 (1), P30CA015083 (1), P30CA016672 (1), UG1CA242609 (1)